unknown and beset by confounding factors1. Strong medical and nursing leadership and effective communication and collaboration have been highlighted as predictors of better outcome of treatment along with good organization of nursing staff2. What about medical organization? We would expect organization within medicine to affect standards of care and outcome, and of prime importance might be continuity of care.
The General Medical Council advises doctors that, when off duty, they must ensure that arrangements are made for their patients' medical care including effective hand-over procedures and clear communication between doctors3. In a National Health Service (NHS) hospital, responsibility for care need not make doctors anxious from a legal point of view because it is the Trust that is responsible for the standard, not the doctor. For this reason, within hospitals continuity of care is an organizational matter for which the clinician has an ethical but not a legal responsibility. By contrast, in a private hospital the doctor assumes responsibility for 24-hour cover on accepting the patient, so that he or she is solely responsible for continuity of care or must personally make alternative arrangements. Why does this not happen in the NHS? Principally because there are too many patients per consultant-and the reduction in hours worked by trainees has made matters worse. Of course, these difficulties pertain only to the clinical specialties in which work outside social hours is a regular feature. They are not an issue in, say, dermatology, radiology or anaesthesia, where 'shifts' or regular hours of working can be appropriate. There has recently been a trend for hospital doctors to work in subspecialty teams or in disease oriented groups. This team approach, with Royal College guidelines and locally produced protocols, encourages shared and standardized care and facilitates continuity of care.
Continuity of care is not only a part of the duty of care but also an integral part of the medical ethic. We do not know what patients and their relatives expect in terms of continuity of care, but we believe they and doctors should want a named consultant or general practitioner to be responsible for provision of care and to ensure continuity. Patients will understand that some aspects of care have to be delegated to others and that, on occasion, responsibility must be passed to some other named principal. A recognized multi-consultant team approach, and the knowledge that the team has responsibility and 'ownership' of their disease management, might indeed give them more confidence. Can a standard of continuity be set? This issue needs to be resolved in the interests of doctors working in the acute areas of medicine, and more importantly their London: GMC, 1995 Medical editors' trial amnesty Randomized controlled trials are the foundation of safe and effective health care. However, a substantial proportion of all controlled trials never contribute to this knowledge base because they are not submitted for publication1l2. This fact has important implications for patient care. First, underreporting of trials reduces the power of systematic reviews to detect moderate but clinically important treatment effects. As a result, patients may be denied effective forms of health care. Second, since trials that show promising treatment effects are more likely to be submitted for publication, research syntheses based on published studies can give misleading conclusions about treatment effectiveness, thus exposing patients to useless or even harmful therapies3. Third, patients may be asked to participate in new research studies designed to address questions that have, in truth, already been answered4.
Trials go unreported for a myriad of reasons: the most common is that investigators think the results are 'not interesting', and trials with non-significant results are substantially less likely to be submitted for publication1. Sometimes participant recruitment takes longer than anticipated, at the expense of time and resources set aside for report writing; investigators may change jobs so that important work remains unfinished; or they may discover a recently published trial on the same topic and conclude that their results are now redundant. Many investigators regret not having published their trial results, and almost all, when contacted, are delighted to provide their unreported data.
Because of the important consequences of unreported trials, the editors of nearly 100 international medical journals have joined together to call an unreported-trial amnesty. All investigators with unreported trial data are urged to register their trial or trials by filling in and returning an unreported-trial registration form (below). The aim is to register any unreported controlled trial, including trials that have only been published as an abstract. Registration can be undertaken by anyone able to supply the registration information, even if they are unable to provide the actual trial data. We expect a degree of duplicate registration. Registration information can be posted or faxed to the editorial office of the JRSM. Alternatively, registration information can be sent by E-mail (meta@ ucl.ac.uk). The information will be made available by listing the trial details on a Web site, and in other ways as appropriate. If specific trial data are required, for example by those conducting systematic reviews, then the reviewer will be able to seek this information directly from the trialist. Some of the trials may be suitable for full publication, and the JRSM will be happy to consider these.
